Updated:
NeoMed
NeoMed Management is an international investment firm focused on the healthcare and life science industry. Founded in 1996, the firm has established four funds...
NeoMed
NeoMed Management is an international investment firm focused on the healthcare and life science industry. Founded in 1996, the firm has established four funds with total committed capital exceeding $200 million. NeoMed invests in companies with growth prospects in pharmaceuticals, biotechnology drugs, diagnostics, medical devices and instruments.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
Europe
Country
United Kingdom
City
Jersey
Corporate office
Jersey, United Kingdom
Principals
James Burt
Founder and Managing Partner
Sector focus
Frequently asked questions
What is NeoMed's investment focus?
NeoMed invests exclusively in life sciences, covering therapeutics, medical devices, diagnostics, and health technology companies. The firm targets opportunities from pre-clinical through commercial stages, primarily in Europe and the United States.
How does NeoMed structure its investments?
NeoMed operates a concentrated direct investment model, typically leading or co-leading financing rounds. The firm runs a small portfolio of active positions, allowing it to work closely with management teams on clinical and regulatory milestones.
Who leads investment decisions at NeoMed?
James Burt, the founder and managing partner, leads investment decisions. He established the firm in 2013 after prior experience at a European life sciences investment platform.
Does NeoMed invest outside of healthcare?
No. NeoMed is a pure-play life sciences investor and does not allocate capital to technology, consumer, industrials, or any sector outside of healthcare.
In which geographies does NeoMed operate?
NeoMed invests primarily in European and US-based life sciences companies. Its Jersey headquarters serves as the fund's administrative and decision-making center.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: